PubMed:17151160 / 1149-1385
Annnotations
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 0-236 | Sentence | denotes | Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 3680 | 19-30 | DiseaseOrPhenotypicFeature | denotes | weight gain | MESH:D015430 |
| 3681 | 45-55 | ChemicalEntity | denotes | olanzapine | MESH:C076029 |
| 3682 | 66-77 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
| 3683 | 178-188 | ChemicalEntity | denotes | olanzapine | MESH:C076029 |
| 3684 | 224-235 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 95-106 | GeneOrGeneProduct | denotes | weight at 4 |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 95-106 | GeneOrGeneProduct | denotes | weight at 4 |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T8 | 19-30 | DiseaseOrPhenotypicFeature | denotes | weight gain | D015430 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 95-106 | GeneOrGeneProduct | denotes | weight at 4 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T9 | 19-30 | DiseaseOrPhenotypicFeature | denotes | weight gain | D015430 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T9 | 19-30 | DiseaseOrPhenotypicFeature | denotes | weight gain | D015430 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T25 | 45-55 | ChemicalEntity | denotes | olanzapine | D000077152|http://purl.obolibrary.org/obo/CHEBI_7735 |
| T27 | 66-77 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
| T29 | 178-188 | ChemicalEntity | denotes | olanzapine | D000077152|http://purl.obolibrary.org/obo/CHEBI_7735 |
| T31 | 224-235 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T31 | 224-235 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
| T29 | 178-188 | ChemicalEntity | denotes | olanzapine | http://purl.obolibrary.org/obo/CHEBI_7735|D000077152 | |
| T27 | 66-77 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
| T25 | 45-55 | ChemicalEntity | denotes | olanzapine | http://purl.obolibrary.org/obo/CHEBI_7735|D000077152 | |
| T78543 | 95-106 | GeneOrGeneProduct | denotes | weight at 4 | ||
| T17021 | 19-30 | DiseaseOrPhenotypicFeature | denotes | weight gain | D015430 |